"paper"

In this paper recently published in Acta Neuropathologica the authors report on neuropathological findings from autopsy for a study cohort of seven COVID-19 patients, all of whom were positive for SARS-CoV-2 by nasopharyngeal swab testing, and compare their observations with those made in a SARS-CoV-2 negative control autopsy cohort comprising individuals with non-septic and systemic inflammatory/septic clinical courses.

The clinical syndrome of COVID-19 infection is complex and implies multiorgan involvement.

In this paper, recently published in the Journal of Neurology, the authors report neurological manifestations in 404 consecutive patients with COVID-19 seen in outpatient clinics and hospitalised between February 20, 2020 and May 4, 2020 at Evergreen Hospital, Kirkland, Washington, USA.

In this paper, recently published in Movement Disorders, the authors explored, through a structured questionnaire, the potential effects of COVID-19 pandemic and lockdown on cognition in Parkinson’s Disease (PD) patients. In particular, they studied 28 PD patients with cognitive disturbance (10 PD with subjective cognitive complaints [SCI]; 10 PD with mild cognitive impairment [MCI] and 8 PD with dementia [PDD]).

In this paper, recently published in the European Journal of Neurology, the authors identified and performed in depth clinical characterisation of a new type of delayed onset movement disorder in five patients who were admitted to the AP-HP intensive care unit (ICU) units for severe SARS-CoV-2 infection.

In this paper, recently published in Annals of Internal Medicine, the authors describe 3 patients without previous neurological or autoimmune disorders who were diagnosed with myasthenia gravis after the onset of coronavirus disease 2019 (COVID-19).

In this paper, recently published in Clinical Infectious Diseases, the authors report a laboratory confirmed SARS-CoV-2 re-infection in a patient which occurred 4.5 months after the first episode.

Rapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic.

A paper has just been published – Collaboration between palliative care and neurology: a survey of clinicians in Europe.

This Guideline addresses a number of medical issues which neurologists and other medical doctors who are involved in the medical management of patients with dementia are confronted with on a regular basis.

In this paper, the authors retrospectively reviewed all COVID-19–positive patients admitted to the neuroscience intensive care unit for monitoring of malignant cerebral oedema

In this paper recently published in Acta Neuropathologica, the authors report neuropathology of two COVID-19 patients.

In this paper, the authors pooled all consecutive patients hospitalised with laboratory-confirmed COVID-19 and acute ischaemic stroke across 28 sites from 16 countries.

In this paper, the authors report a case of a previously healthy 58-year-old man who acutely developed hyposmia, generalised myoclonus, fluctuating and transient changes in level of consciousness, opsoclonus and an asymmetric hypokinetic-rigid syndrome with ocular abnormalities following severe SARS-CoV-2 infection.

In this paper recently published in the official journal of the Hungarian Society of Neurologists, the authors discuss neurological signs and symptoms in COVID-19 patients; the effects of COVID-19 on services for other acute diseases; and changes in the care for patients with chronic neurological disorders.